Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 17077279)

1.

Rosiglitazone inhibits mouse liver regeneration.

Turmelle YP, Shikapwashya O, Tu S, Hruz PW, Yan Q, Rudnick DA.

FASEB J. 2006 Dec;20(14):2609-11. Epub 2006 Oct 31.

2.

Elucidating the metabolic regulation of liver regeneration.

Huang J, Rudnick DA.

Am J Pathol. 2014 Feb;184(2):309-21. doi: 10.1016/j.ajpath.2013.04.034. Epub 2013 Oct 17. Review.

3.

Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation.

Ben Ya'acov A, Lalazar G, Zolotaryova L, Steinhardt Y, Lichtentein Y, Ilan Y, Shteyer E.

J Dig Dis. 2013 Aug;14(8):425-32. doi: 10.1111/1751-2980.12062.

PMID:
23575221
4.

Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.

Wagnerberger S, Spruss A, Kanuri G, Stahl C, Schröder M, Vetter W, Bischoff SC, Bergheim I.

J Nutr Biochem. 2013 Mar;24(3):531-8. doi: 10.1016/j.jnutbio.2012.01.014. Epub 2012 Jun 27.

PMID:
22749137
5.

Analysis of the role of hepatic PPARγ expression during mouse liver regeneration.

Gazit V, Huang J, Weymann A, Rudnick DA.

Hepatology. 2012 Oct;56(4):1489-98. doi: 10.1002/hep.25880.

6.

Functional Relationships between Lipid Metabolism and Liver Regeneration.

Rudnick DA, Davidson NO.

Int J Hepatol. 2012;2012:549241. doi: 10.1155/2012/549241. Epub 2012 Jan 26.

7.

Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.

Kakiuchi-Kiyota S, Arnold LL, Yokohira M, Koza-Taylor P, Suzuki S, Varney M, Pennington KL, Cohen SM.

Toxicol Pathol. 2011 Dec;39(7):1032-45. doi: 10.1177/0192623311422080. Epub 2011 Sep 21.

8.

The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.

Takahashi Y, Hasegawa-Moriyama M, Sakurai T, Inada E.

Anesth Analg. 2011 Aug;113(2):398-404. doi: 10.1213/ANE.0b013e31821b220c. Epub 2011 Apr 13.

PMID:
21490083
10.

Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.

Mansour M, Schwartz D, Judd R, Akingbemi B, Braden T, Morrison E, Dennis J, Bartol F, Hazi A, Napier I, Abdel-Mageed AB.

Int J Oncol. 2011 Feb;38(2):537-46. doi: 10.3892/ijo.2010.877. Epub 2010 Dec 17.

PMID:
21170507
11.

A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.

Yuan Y, Zhang A, Huang S, Ding G, Chen R.

Am J Physiol Renal Physiol. 2011 Feb;300(2):F393-402. doi: 10.1152/ajprenal.00418.2010. Epub 2010 Dec 1.

12.

PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.

Kim MK, Chae YN, Choi SH, Moon HS, Son MH, Bae MH, Choi HH, Hur Y, Kim E, Park YH, Park CS, Kim JG, Lim JI, Shin CY.

Eur J Pharmacol. 2011 Jan 15;650(2-3):673-81. doi: 10.1016/j.ejphar.2010.10.044. Epub 2010 Oct 23.

PMID:
20974124
13.

Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice.

Gazit V, Weymann A, Hartman E, Finck BN, Hruz PW, Tzekov A, Rudnick DA.

Hepatology. 2010 Dec;52(6):2109-17. doi: 10.1002/hep.23920. Epub 2010 Oct 21.

14.
15.

Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.

Yang Q, Chen C, Wu S, Zhang Y, Mao X, Wang W.

Eur J Pharmacol. 2010 Dec 15;649(1-3):108-14. doi: 10.1016/j.ejphar.2010.09.025. Epub 2010 Sep 20.

PMID:
20863825
16.

[The effect of rosiglitazone on the cell proliferation and the expressions of p27 and skp2 in helicobacter pylori infected human gastric epithelial cells].

Kim SS, Cho YS, Kim HK, Shin OR, Chae HS, Choi MG, Chung IS.

Korean J Gastroenterol. 2010 Apr;55(4):225-31. Korean.

17.

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.

Collino M, Aragno M, Castiglia S, Miglio G, Tomasinelli C, Boccuzzi G, Thiemermann C, Fantozzi R.

Br J Pharmacol. 2010 Aug;160(8):1892-902. doi: 10.1111/j.1476-5381.2010.00671.x. Epub 2010 Mar 8.

18.

Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.

Wu Y, Zhao XD, Zhuang Z, Xue YJ, Cheng HL, Yin HX, Shi JX.

Brain Res. 2010 Mar 31;1322:102-8. doi: 10.1016/j.brainres.2010.01.073. Epub 2010 Feb 2.

PMID:
20132800
19.

Deregulation of growth factor, circadian clock, and cell cycle signaling in regenerating hepatocyte RXRalpha-deficient mouse livers.

Yang X, Guo M, Wan YJ.

Am J Pathol. 2010 Feb;176(2):733-43. doi: 10.2353/ajpath.2010.090524. Epub 2009 Dec 24.

20.

IL-22 is involved in liver regeneration after hepatectomy.

Ren X, Hu B, Colletti LM.

Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G74-80. doi: 10.1152/ajpgi.00075.2009. Epub 2009 Oct 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk